Precigen Stock Performance
PGEN Stock | USD 1.38 0.05 3.76% |
Precigen has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of -0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Precigen are expected to decrease at a much lower rate. During the bear market, Precigen is likely to outperform the market. Precigen right now holds a risk of 3.84%. Please check Precigen kurtosis, day typical price, as well as the relationship between the potential upside and total risk alpha , to decide if Precigen will be following its historical price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Precigen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Precigen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
1 | Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Mondays Pre-Market ... - Markets Insider | 02/12/2024 |
2 | Does Precigen Inc Have What it Takes to be in Your Portfolio Tuesday - InvestorsObserver | 02/27/2024 |
3 | Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th | 03/05/2024 |
4 | Disposition of 213675 shares by Kirk Randal J of Precigen subject to Rule 16b-3 | 03/08/2024 |
5 | Precigen Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat | 03/11/2024 |
6 | Acquisition by Frank Steven of 87412 shares of Precigen subject to Rule 16b-3 | 03/14/2024 |
7 | Precigen Reports Full Year 2023 Financial Results and Business Updates | 03/19/2024 |
8 | Germantown biotech expands manufacturing capacity, headcount ahead of potential product launch | 03/20/2024 |
9 | Precigen Stock Rating Upgraded by StockNews.com - MarketBeat | 03/26/2024 |
10 | Precigen to Host a Virtual RD Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose ... - The Globe and Mail | 04/03/2024 |
11 | Disposition of 164285 shares by Donald Lehr of Precigen subject to Rule 16b-3 | 04/05/2024 |
12 | Acquisition by Harry Thomasian of 135714 shares of Precigen subject to Rule 16b-3 | 04/09/2024 |
13 | Bleakley Financial Group LLC Decreases Stock Position in Precigen, Inc. - Defense World | 04/17/2024 |
Begin Period Cash Flow | 48.2 M |
Precigen |
Precigen Relative Risk vs. Return Landscape
If you would invest 139.00 in Precigen on January 24, 2024 and sell it today you would lose (1.00) from holding Precigen or give up 0.72% of portfolio value over 90 days. Precigen is currently generating 0.0616% in daily expected returns and assumes 3.8411% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Precigen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Precigen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Precigen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Precigen, and traders can use it to determine the average amount a Precigen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.016
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | PGEN | Huge Risk |
Negative Returns |
Estimated Market Risk
3.84 actual daily | 33 67% of assets are more volatile |
Expected Return
0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Precigen is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Precigen by adding it to a well-diversified portfolio.
Precigen Fundamentals Growth
Precigen Stock prices reflect investors' perceptions of the future prospects and financial health of Precigen, and Precigen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precigen Stock performance.
Return On Equity | -0.78 | ||||
Return On Asset | -0.3 | ||||
Operating Margin | (19.05) % | ||||
Current Valuation | 275.3 M | ||||
Shares Outstanding | 248.92 M | ||||
Price To Earning | (2.06) X | ||||
Price To Book | 3.00 X | ||||
Price To Sales | 56.78 X | ||||
Revenue | 6.22 M | ||||
Gross Profit | 20.57 M | ||||
EBITDA | (82.25 M) | ||||
Net Income | (95.9 M) | ||||
Cash And Equivalents | 115.3 M | ||||
Cash Per Share | 0.55 X | ||||
Total Debt | 7.1 M | ||||
Debt To Equity | 3.73 % | ||||
Current Ratio | 5.51 X | ||||
Book Value Per Share | 0.48 X | ||||
Cash Flow From Operations | (66.93 M) | ||||
Earnings Per Share | (0.39) X | ||||
Market Capitalization | 331.06 M | ||||
Total Asset | 151.04 M | ||||
Retained Earnings | (1.96 B) | ||||
Working Capital | 45.77 M | ||||
Current Asset | 285.72 M | ||||
Current Liabilities | 66.91 M | ||||
About Precigen Performance
To evaluate Precigen Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Precigen generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Precigen Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Precigen market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Precigen's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 19.00 | 18.05 | |
Return On Tangible Assets | (1.15) | (1.20) | |
Return On Capital Employed | (0.69) | (0.73) | |
Return On Assets | (0.63) | (0.67) | |
Return On Equity | (0.81) | (0.85) |
Things to note about Precigen performance evaluation
Checking the ongoing alerts about Precigen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Precigen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Precigen may become a speculative penny stock | |
Precigen had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 6.22 M. Net Loss for the year was (95.9 M) with profit before overhead, payroll, taxes, and interest of 20.57 M. | |
Precigen currently holds about 115.3 M in cash with (66.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. | |
Roughly 64.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: Bleakley Financial Group LLC Decreases Stock Position in Precigen, Inc. - Defense World |
- Analyzing Precigen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precigen's stock is overvalued or undervalued compared to its peers.
- Examining Precigen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Precigen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precigen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Precigen's stock. These opinions can provide insight into Precigen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.Note that the Precigen information on this page should be used as a complementary analysis to other Precigen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Precigen Stock analysis
When running Precigen's price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Precigen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.39) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.30) | Return On Assets (0.30) | Return On Equity (0.78) |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.